BackDeciphera Pharmaceuticals Overview

Deciphera Pharmaceuticals Selling, General & Admin

Selling, General & Admin expenses for DCPH.

Quarterly SG&A Expenses

$32.78M
↑ 4.22% YoY

As of Mar 31, 2024

Annual SG&A Expenses (TTM)

$137.79M
↑ 11.75% YoY

Trailing 12 months ending Mar 31, 2024

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin